Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
* Tensions with Hungary's Orban rising before EU summit* Hungary to be first EU country to import, trial Sputnik V* EU: Move raises concerns for safety, confidence in vaccineBy Francesco GuarascioBRUSSELS, Nov 19 (Reuters) - Hungary's plans to import...
Read more
(Sharecast News) - Analysts at Berenberg struck a positive note on AstraZeneca shares after the drugmaker published full immunogenicity data earlier in the session for its Covid-19 vaccine candidate, AZD 1222.
Read more
UK TOP NEWS SUMMARY: Oxford-Astra Vaccine Encouraging In Older Adults
Read more* European shares fall led by oil, banks* Rising U.S. virus cases and lockdowns sour mood* STOXX down 0.9% after late Wall Street sell-off* U.S. stock index futures inch lower Welcome to the home for real-time coverage of markets brought to you by ...
Read more(Adds details from briefing)By Kate Kelland and Alistair SmoutLONDON, Nov 19 (Reuters) - AstraZeneca and Oxford University's potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with rese...
Read more(Adds chief investigator saying Phase 3 results before year-end)By Kate KellandLONDON, Nov 19 (Reuters) - AstraZeneca and Oxford University's potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday ...
Read more(Sharecast News) - AstraZeneca's potential Covid-19 vaccine showed a strong immune response in older people, suggesting it may protect some of those most susceptible to the virus, trial data showed.
Read moreLONDON MARKET OPEN: NY Restrictions And Japan Virus Alert Damp Spirits
Read more* European shares open lower* Rising U.S. virus cases and lockdowns sour mood* STOXX down 0.7% after late Wall Street sell-off* U.S. stock index futures inch lower Welcome to the home for real-time coverage of markets brought to you by Reuters repo...
Read moreLONDON, Nov 19 (Reuters) - Results of late-stage trials of University of Oxford's COVID-19 vaccine candidate should definitely be known by Christmas, the chief investigator on the study said on Thursday, adding it was too early to know its effica...
Read moreTOP NEWS: Oxford Vaccine Shows Strong Immune Response In Older Adults
Read more* European shares seen opening lower* Rising U.S. virus cases and lockdowns sour mood* Euro STOXX 50 and FTSE futures down nearly 1% Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoug...
Read moreBy Kate KellandLONDON, Nov 19 (Reuters) - A potential COVID-19 vaccine developed by AstraZeneca Plc and Oxford University produced a strong immune response in older adults, giving hope it may protect some of those most vulnerable to the disease, ...
Read moreNov 18 (Reuters) - Pfizer Inc's and Moderna Inc's COVID-19 vaccine candidates could be ready for U.S. authorization and distribution within weeks, setting the stage for widespread inoculation to begin as soon as this year, U.S. Health and Human S...
Read more* If all goes well, approval seen mid-Dec* BioNTech CEO says market will welcome up to 8 vaccines* CEO says working on more temperature resistant formulation (Adds details on competitive setting, new formulation)By Ludwig Burger and Patricia WeissFR...
Read more
Last checked at